| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.36 | 2e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-09 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.23 | 6e-09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-07 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 9e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.31 | 1e-06 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.28 | 6e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |